Page last updated: 2024-12-09
xantphos
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
xantphos: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
ID Source | ID |
---|---|
PubMed CID | 636044 |
SCHEMBL ID | 124677 |
SCHEMBL ID | 6953 |
MeSH ID | M0509958 |
Synonyms (93)
Synonym |
---|
AC-4980 |
c39h32op2 |
xantphos, 97% |
B2709 , |
xantphos |
4,5-bis(diphenylphosphino)-9,9-dimethylxanthene |
161265-03-8 |
AKOS005145677 |
(5-diphenylphosphanyl-9,9-dimethylxanthen-4-yl)-diphenylphosphane |
A810241 |
(9,9-dimethyl-9h-xanthene-4,5-diyl)bis(diphenylphosphine) |
4,5-bis(diphenylphospheno)-9,9-dimethyl xanthene |
9,9-dimethyl-4,5-bis(diphenylphosphino)xanthene |
4,5-bis-diphenylphosphanyl-9,9-dimethyl-9h-xanthene |
(9,9-dimethyl-9h-xanthene-4,5-diyl)bis[diphenyl phosphine] |
FT-0645040 |
GC10163 |
AM84537 |
(9,9-dimethyl-9h-xanthene-4,5-diyl)bis(diphenylphosphane) |
BP-12287 |
SCHEMBL124677 |
4,5-bis(diphenylphosphino)-9,9-dimethyl-xanthene |
SCHEMBL6953 |
mfcd00233866 |
SY002425 |
J-501712 |
9,9-dimethyl-4,5-bis(diphenylphosphino)-9h-xanthen |
4,5-bis(diphenylphosphino)-9,9-dimehtylxanthene |
(9,9-dimethyl-9h-xanthen-4,5-diyl)bis(diphenylphosphine) |
9,9-dimethyl-4,5-bis-(diphenylphosphino)xanthene |
4,5-bis-(diphenylphosphino)9,9-dimethylxanthene |
4,5-bis(diphenyl-phosphino)-9,9-dimethyl-9h-xanthene |
4,5-bis(diphenyl phosphino)-9,9-dimethyl xanthene |
(5-diphenylphosphanyl-9,9-dimethyl-xanthen-4-yl)-diphenyl-phosphane |
4,5-bis(diphenyl phosphino)-9,9-dimethylxanthene |
(9,9-dimethyl-9h-xanthene-4,5-diyl)-bis(diphenylphosphine) |
4,5 bis(diphenyl-phosphino)-9,9-dimethylxanthene |
(9,9-dimethyl-9h-xanthene-4,5-diyl)bis-(diphenylphosphine) |
9,9-dimethyl-4,5-bis(diphenylphospino)xanthene |
xanthphos |
9,9-dimethyl-4,5-bis(diphenylphosphino)-xanthene |
4,5-bis(diphenyl-phosphino)-9,9-dimethylxanthene |
4,5-bis-(diphenylphosphino)-9,9-dimethylxanthene |
4,5-bis-(diphenylphosphanyl)-9,9-dimethyl-9h-xanthene |
9,9-dimethyl4,5-bis(diphenylphosphino)xanthene |
9,9-dimethyl-4,5-bis(diphenyl-phosphino)xanthene |
9,9-dimethyl-4,5-bis(diphenyl phosphino)xanthene |
4,5-bis(diphenylphos-phino)-9,9-dimethylxanthene |
4,5-bis(diphenylphosphino)-9,9-dimethyxanthene |
4,5-bis(diphenylphoshino)-9,9-dimethylxanthene |
4,5-bisdiphenylphosphanyl-9,9-dimethyl-9h-xanthene |
4,5-bis(diphenylphosphino)-9,9-dimethyl-9h-xanthene |
9,9-dimethyl-4,5-bis (diphenylphosphino)xanthene |
4,5bis(diphenylphosphino)-9,9-dimethylxanthene |
4,5-bis(diphenylphosphino)-9,9-dimethyl xanthene |
(9,9-dimethyl-9h-xanthene-4,5-diyl)bis(di-phenylphosphine) |
[5-(diphenylphosphanyl)-9,9-dimethyl-9h-xanthen-4-yl]diphenylphosphane |
4,5-bis (diphenylphosphino) -9,9-dimethylxanthene |
9,9-dimethyl-4,5-bis-(diphenylphosphino)-xanthene , |
4,5-bis(diphenyl)phosphino-9,9-dimethylxanthene |
4.5-bis(diphenylphosphino)-9,9-dimethylxanthene |
4,5-bis(diphenylphosphino)-9,9-dimethlxanthene |
9,9-dimethyl-4,5-bis(diphenylphoshino)xanthene |
9,9-dimethyl-4,5-bis(diphenylphosphino) xanthene |
4,5-bis(diphenylphosphino)-9,9 dimethylxanthene |
4,5-bis(diphenylphosphino) 9,9-dimethylxanthene |
(9,9-dimethyl-9h-xanthene-4,5-diyl)bis[diphenylphosphine] |
4,5-bis(diphenylphophino)-9,9-dimethylxanthene |
4,5-bis (diphenylphosphino)-9,9-dimethylxanthene |
9,9-dimethyl-4,5-bis(diphenyl-phosphino)-xanthene |
Y-200029 |
STR08712 |
unii-nmu72mog9b |
phosphine, (9,9-dimethyl-9h-xanthene-4,5-diyl)bis[diphenyl- |
xantphos [mi] |
phosphine, 1,1'-(9,9-dimethyl-9h-xanthene-4,5-diyl)bis(1,1-diphenyl- |
NMU72MOG9B , |
[5-(diphenylphosphino)-9,9-dimethyl-9h-xanthen-4-yl](diphenyl)phosphine # |
xanthene, 4,5-bis(diphenylphosphino)-9,9-dimethyl- |
DTXSID20348350 |
CS-D1124 |
BBL102416 |
STL556218 |
BCP05531 |
fmoc-2-amino-5-chlorobenzoicacid |
Z337707760 |
dimethyl bisdiphenylphosphinoxanthene |
us9745317, 3 |
bdbm337365 |
5-[4-(2,3-dihydrofuro[3,2-c]pyridin-4-yloxy)phenyl]-4,6-dimethylpyridazin-3(2h)-one (3) |
Q2135551 |
phosphine, 1,1'-(9,9-dimethyl-9h-xanthene-4,5-diyl)bis[1,1-diphenyl- |
EN300-32025 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (27)
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 5 (18.52) | 29.6817 |
2010's | 16 (59.26) | 24.3611 |
2020's | 6 (22.22) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 54.82
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.
| This Compound (54.82) All Compounds (24.57) |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 27 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |